12-110914159-GACAC-GACACACAC
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_000432.4(MYL2):c.274+23_274+26dupGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000407 in 1,376,718 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0016 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00026 ( 1 hom. )
Consequence
MYL2
NM_000432.4 intron
NM_000432.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.360
Genes affected
MYL2 (HGNC:7583): (myosin light chain 2) This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 12-110914159-G-GACAC is Benign according to our data. Variant chr12-110914159-G-GACAC is described in ClinVar as [Benign]. Clinvar id is 1329421.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 241 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL2 | NM_000432.4 | c.274+23_274+26dupGTGT | intron_variant | ENST00000228841.15 | NP_000423.2 | |||
MYL2 | NM_001406745.1 | c.232+23_232+26dupGTGT | intron_variant | NP_001393674.1 | ||||
MYL2 | NM_001406916.1 | c.217+23_217+26dupGTGT | intron_variant | NP_001393845.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL2 | ENST00000228841.15 | c.274+23_274+26dupGTGT | intron_variant | 1 | NM_000432.4 | ENSP00000228841.8 | ||||
MYL2 | ENST00000548438.1 | c.232+23_232+26dupGTGT | intron_variant | 3 | ENSP00000447154.1 | |||||
MYL2 | ENST00000663220.1 | c.217+23_217+26dupGTGT | intron_variant | ENSP00000499568.1 | ||||||
MYL2 | ENST00000549029.1 | n.105+23_105+26dupGTGT | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00155 AC: 233AN: 150034Hom.: 2 Cov.: 31
GnomAD3 genomes
AF:
AC:
233
AN:
150034
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000260 AC: 319AN: 1226580Hom.: 1 Cov.: 16 AF XY: 0.000269 AC XY: 166AN XY: 617332
GnomAD4 exome
AF:
AC:
319
AN:
1226580
Hom.:
Cov.:
16
AF XY:
AC XY:
166
AN XY:
617332
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00161 AC: 241AN: 150138Hom.: 2 Cov.: 31 AF XY: 0.00161 AC XY: 118AN XY: 73214
GnomAD4 genome
AF:
AC:
241
AN:
150138
Hom.:
Cov.:
31
AF XY:
AC XY:
118
AN XY:
73214
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Sep 30, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at